Activation of cyclin-dependent kinase 5 is a consequence of cell death

Yixia Ye1, Antonella Tinari, Walter Malorni

  • 1Department of Biology, Queens College and Graduate Center of the City University of New York, Flushing, NY 11367, USA.

Insights

Cyclin-dependent kinase 5 (Cdk5) activation occurs during cell death, but is not required for it. This kinase activation is a consequence of metabolic changes, not a cause of cell death.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Molecular Biology

Background:

  • Cyclin-dependent kinase 5 (Cdk5) plays roles in cell differentiation and death, distinct from its cell division roles.
  • Cdk5 activation has been observed in various cell death scenarios, prompting investigation into its necessity.

Purpose of the Study:

  • To determine if Cyclin-dependent kinase 5 (Cdk5) is essential for any form of cell death.
  • To investigate the mechanisms and triggers of Cdk5 activation during apoptosis and secondary necrosis.

Main Methods:

  • Assessing Cdk5 activation during apoptotic cell death and secondary necrosis.
  • Utilizing calpain inhibition and RNA interference (RNAi) to suppress Cdk5 synthesis.
  • Examining the role of Bim, calpain, and neutral cathepsins in Cdk5 activation.

Main Results:

  • Cdk5 is activated during apoptotic cell death, persisting into secondary necrosis.
  • Cdk5 activation occurs independently of Bim, calpain, or neutral cathepsins.
  • Calpain inhibition and Cdk5 suppression via RNAi did not affect cell death incidence or kinetics.

Conclusions:

  • Cdk5 activation is a consequence of metabolic alterations common to various cell death pathways.
  • While Cdk5 activation indicates significant cellular events, it is not a prerequisite for cell death.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...